Subtotal Resection of Large Acoustic Neuromas With Possible Stereotactic Radiation Therapy
Multicenter Prospective Analysis of Treatment Outcome in Patients With Large Acoustic Neuromas
1 other identifier
observational
157
1 country
9
Brief Summary
The investigators study is to investigate safety and efficacy of performing a planned incomplete removal of large acoustic neuroma tumors to decrease surgical morbidity and yet avoid tumor recurrence by post-operative radiation therapy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2005
Longer than P75 for all trials
9 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2005
CompletedFirst Submitted
Initial submission to the registry
March 10, 2010
CompletedFirst Posted
Study publicly available on registry
May 25, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 8, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
May 8, 2022
CompletedMay 10, 2022
May 1, 2022
17.2 years
March 10, 2010
May 8, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Need for stereotactic radiation therapy should tumor remnant grow on annual MRI's
10 years
Secondary Outcomes (1)
Facial nerve function measured on House-Brackmann scale
10 y
Study Arms (1)
ANSRS group
Patients qualifying for the study.
Interventions
Patient would under to total, near-total, or subtotal resection of tumor
Patient who has sign of growth of tumor remnant would undergo this treatment
Eligibility Criteria
Patients with large acoustic neuromas measuring 2.5cm in longest dimension in the cerebellopontine angle.
You may qualify if:
- Adult patients with acoustic neuromas the widest diameter of 2.5 cm or larger at the cerebellopontine angle are eligible for this trial.
- Patients that are deemed good surgical candidates based on age, general health, genetic predispositions, and hearing in contralateral side would be included as the subjects of this trial.
- Although we would include patients with neurofibromatosis II in this trial, considering their genetic predisposition for recurrence, we would analyze their outcome as a separate group.
You may not qualify if:
- Patients who have received any form of treatment of their acoustic neuromas prior to enrollment in the study including surgery or radiation therapy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Stanford Universitylead
- University of Cincinnaticollaborator
- Baylor College of Medicinecollaborator
- Weill Medical College of Cornell Universitycollaborator
- University of Iowacollaborator
- University of Texascollaborator
- George Washington Universitycollaborator
- Indiana Universitycollaborator
- Louisiana State University Health Sciences Center in New Orleanscollaborator
Study Sites (9)
Stanford University School of Medicine
Stanford, California, 94305, United States
George Washington University
Washington D.C., District of Columbia, 20037, United States
Indiana University
Indianapolis, Indiana, 46202, United States
University of Iowa
Iowa City, Iowa, 52242, United States
Louisiana State University
Baton Rouge, Louisiana, 70808, United States
Weill Cornell Medical College
New York, New York, United States
University of Cincinnati
Cincinnati, Ohio, United States
University of Texas Southwestern
Dallas, Texas, 75390, United States
Baylor College of Medicine
Houston, Texas, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Ashkan Monfared, MD
George Washington University
- STUDY DIRECTOR
Robert K Jackler, MD
Stanford University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
March 10, 2010
First Posted
May 25, 2010
Study Start
March 1, 2005
Primary Completion
May 8, 2022
Study Completion
May 8, 2022
Last Updated
May 10, 2022
Record last verified: 2022-05